Cara Therapeutics, Inc. Annual Operating Income (Loss) in USD from 2012 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Cara Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2012 to 2023.
  • Cara Therapeutics, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$5.99M, a 79.3% increase year-over-year.
  • Cara Therapeutics, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$85.6M, a 28.8% increase year-over-year.
  • Cara Therapeutics, Inc. annual Operating Income (Loss) for 2023 was -$121M, a 38.8% decline from 2022.
  • Cara Therapeutics, Inc. annual Operating Income (Loss) for 2022 was -$87.5M, a 1.74% increase from 2021.
  • Cara Therapeutics, Inc. annual Operating Income (Loss) for 2021 was -$89.1M, a 1754% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$121M -$34M -38.8% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-06
2022 -$87.5M +$1.55M +1.74% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-06
2021 -$89.1M -$94.5M -1754% Jan 1, 2021 Dec 31, 2021 10-K 2024-03-06
2020 $5.39M +$117M Jan 1, 2020 Dec 31, 2020 10-K 2023-03-06
2019 -$112M -$34.3M -44.3% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-01
2018 -$77.4M -$17.9M -30.1% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-25
2017 -$59.5M -$1.09M -1.86% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-27
2016 -$58.4M -$33.2M -132% Jan 1, 2016 Dec 31, 2016 10-K 2019-03-12
2015 -$25.2M -$7.12M -39.4% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-15
2014 -$18.1M -$17.8M -7525% Jan 1, 2014 Dec 31, 2014 10-K 2017-03-10
2013 -$237K +$6M +96.2% Jan 1, 2013 Dec 31, 2013 10-K 2016-03-11
2012 -$6.24M Jan 1, 2012 Dec 31, 2012 10-K 2015-03-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.